Page 7 - 2021_07-Haematologica-web

1968 Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling Amanda J. Unsworth et al.
https://doi.org/10.3324/haematol.2019.223529
Red Cell Biology & its Disorders
1979 In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor Aidan G. Gilmartin et al.
https://doi.org/10.3324/haematol.2020.248658
Letters to the Editor
1988 Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation Samer A. Srour, et al.
https://doi.org/10.3324/haematol.2019.223503
1991 Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study Hira S. Mian et al.
https://doi.org/10.3324/haematol.2020.267757
1995 Mixed-lineage leukemia protein modulates the loading of let-7a onto AGO1 by recruiting RAN Shouhai Zhu et al.
https://doi.org/10.3324/haematol.2020.268474
2000 Glenzocimab does not impact glycoprotein VI-dependent inflammatory hemostasis Soumaya Jadoui et al.
https://doi.org/10.3324/haematol.2020.270439
2004 Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma Michelle Kinder et al.
https://doi.org/10.3324/haematol.2020.268656
2009 Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab
Ekaterina Mikhailova et al.
https://doi.org/10.3324/haematol.2019.241596
2013 Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma Matteo Costacurta et al.
https://doi.org/10.3324/haematol.2020.265611
2018 Myocardial injury and coronary microvascular disease in sickle cell disease Kiranveer Kaur et al.
https://doi.org/10.3324/haematol.2020.271254
2022 Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies Adam S. Kittai et al.
https://doi.org/10.3324/haematol.2020.270298
2026 An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia
Yoichi Tanaka et al.
https://doi.org/10.3324/haematol.2020.266320
Case Reports
2030 A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythro- poietic protoporphyria
Sarah Ducamp et al.
https://doi.org/10.3324/haematol.2020.272450
2034 Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two cases Hélène Vergneault et al.
https://doi.org/10.3324/haematol.2020.277137
haematologica Journal of the Ferrata Storti Foundation
Platelet Biology & its Disorders
Haematologica 2021; vol. 106 no. 7 - July 2021 http://www.haematologica.org/